Showing results (51-60 of 81) with videos related to
Sort By:
Pageof 9
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2009
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin EvaluationJean-Yves Douillard, Hélène Tribodet, Delphine Aubert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Phase II study of imatinib in patients with small cell lung cancerBruce E Johnson, Thomas Fischer, Berthold Fischer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2009
Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancerRodrigo Arriagada, Ariane Dunant, Jean-Pierre Pignon, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 26, 2014
Is sacrifying the phrenic nerve during thymoma resection worthwhile?Sarah Hamdi, Olaf Mercier, Elie Fadel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancerMartin Früh, Estelle Rolland, Jean-Pierre Pignon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Vincent Haddad, Katharina Schmid, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancerNermine S Kamal, Jean-Charles Soria, Jean Mendiboure, et al.Molecular Oncology|February 6, 2014
Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancerXiaoli Ma, Vanessa Rousseau, Haiji Sun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panelCesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic ProgramMartin Filipits, Robert Pirker, Ariane Dunant, et al.Pageof 9